Golden State Wealth Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-65
Closed -$943 1667
2025
Q2
$744 Hold
65
﹤0.01% 1462
2025
Q1
$879 Hold
65
﹤0.01% 1441
2024
Q4
$1.1K Buy
+65
New +$1.26K ﹤0.01% 1342
2020
Q2
Sell
-88
Closed -$1K 292
2020
Q1
$1K Buy
+88
New +$1.27K ﹤0.01% 901
2019
Q4
Sell
-88
Closed -$1K 176
2019
Q3
$1K Hold
88
﹤0.01% 1012
2019
Q2
$2K Hold
88
﹤0.01% 968
2019
Q1
$3K Buy
+88
New +$3.2K ﹤0.01% 971

Other funds holding CC

Golden State Wealth Management's CC Position: Q3 2025 in Review

Golden State Wealth Management sold out of Chemours (CC) in Q3 2025, closing a stake of 65 shares — an estimated $943 sold.

Golden State Wealth Management first reported a position in CC in Q1 2019 and held it in 7 quarters. The position peaked at $3K in Q1 2019. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Golden State Wealth Management reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
  • Golden State Wealth Management sold 65 Chemours shares in Q3 2025, an estimated $943.
  • Golden State Wealth Management first reported a position in Chemours in Q1 2019 and held it in 7 quarters.
  • Golden State Wealth Management's Chemours position peaked at $3K in Q1 2019.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Golden State Wealth Management's 13F filing for Q3 2025, filed 3 Nov 2025.